Among these, gene fusions involving the anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1 (ROS1), though rare, are highly significant in the context of lung cancer diagnosis and treatment5,6. The gene discussed is ALK; the disease is lung cancer.